Logo image of ALMEX.PA

MEXEDIA SPA (ALMEX.PA) Stock Fundamental Analysis

EPA:ALMEX - IT0005450819 - Common Stock

60 EUR
-1.5 (-2.44%)
Last: 9/2/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALMEX. ALMEX was compared to 33 industry peers in the Diversified Telecommunication Services industry. No worries on liquidiy or solvency for ALMEX as it has an excellent financial health rating, but there are worries on the profitability. ALMEX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ALMEX had negative earnings in the past year.
In the past year ALMEX had a positive cash flow from operations.
Of the past 5 years ALMEX 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: ALMEX reported negative operating cash flow in multiple years.
ALMEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALMEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

ALMEX has a Return On Assets of -12.70%. This is amonst the worse of the industry: ALMEX underperforms 81.82% of its industry peers.
Looking at the Return On Equity, with a value of -42.25%, ALMEX is doing worse than 81.82% of the companies in the same industry.
Industry RankSector Rank
ROA -12.7%
ROE -42.25%
ROIC N/A
ROA(3y)-1.83%
ROA(5y)2.5%
ROE(3y)-9.5%
ROE(5y)5.81%
ROIC(3y)N/A
ROIC(5y)N/A
ALMEX.PA Yearly ROA, ROE, ROICALMEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

ALMEX has a worse Gross Margin (10.15%) than 81.82% of its industry peers.
ALMEX's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ALMEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.41%
GM growth 5Y36.9%
ALMEX.PA Yearly Profit, Operating, Gross MarginsALMEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

7

2. Health

2.1 Basic Checks

ALMEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALMEX remains at a similar level compared to 1 year ago.
ALMEX has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for ALMEX has been reduced compared to a year ago.
ALMEX.PA Yearly Shares OutstandingALMEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALMEX.PA Yearly Total Debt VS Total AssetsALMEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 1.78, we must say that ALMEX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.78, ALMEX belongs to the top of the industry, outperforming 84.85% of the companies in the same industry.
ALMEX has a debt to FCF ratio of 3.19. This is a good value and a sign of high solvency as ALMEX would need 3.19 years to pay back of all of its debts.
ALMEX has a better Debt to FCF ratio (3.19) than 90.91% of its industry peers.
ALMEX has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALMEX (0.10) is better than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.19
Altman-Z 1.78
ROIC/WACCN/A
WACC7.84%
ALMEX.PA Yearly LT Debt VS Equity VS FCFALMEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

ALMEX has a Current Ratio of 1.12. This is a normal value and indicates that ALMEX is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ALMEX (1.12) is better than 87.88% of its industry peers.
A Quick Ratio of 1.12 indicates that ALMEX should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.12, ALMEX belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.12
ALMEX.PA Yearly Current Assets VS Current LiabilitesALMEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

0

3. Growth

3.1 Past

ALMEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -547.54%.
Looking at the last year, ALMEX shows a very negative growth in Revenue. The Revenue has decreased by -77.49% in the last year.
ALMEX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -13.26% yearly.
EPS 1Y (TTM)-547.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-77.49%
Revenue growth 3Y-17.91%
Revenue growth 5Y-13.26%
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y88.15%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALMEX.PA Yearly Revenue VS EstimatesALMEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
ALMEX.PA Yearly EPS VS EstimatesALMEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 0.5 1 1.5 2 2.5

1

4. Valuation

4.1 Price/Earnings Ratio

ALMEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 22.93, ALMEX is valued on the expensive side.
Based on the Price/Forward Earnings ratio, ALMEX is valued a bit more expensive than the industry average as 69.70% of the companies are valued more cheaply.
ALMEX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.52, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 22.93
ALMEX.PA Price Earnings VS Forward Price EarningsALMEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ALMEX is valued expensively inside the industry as 81.82% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF 217.97
EV/EBITDA N/A
ALMEX.PA Per share dataALMEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

ALMEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALMEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MEXEDIA SPA

EPA:ALMEX (9/2/2025, 7:00:00 PM)

60

-1.5 (-2.44%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.09%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap342.00M
Analysts86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 22.93
P/S 4.69
P/FCF 217.97
P/OCF 41.41
P/B 7.22
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.51
EYN/A
EPS(NY)2.62
Fwd EY4.36%
FCF(TTM)0.28
FCFY0.46%
OCF(TTM)1.45
OCFY2.41%
SpS12.79
BVpS8.31
TBVpS-4.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.7%
ROE -42.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.15%
FCFM 2.15%
ROA(3y)-1.83%
ROA(5y)2.5%
ROE(3y)-9.5%
ROE(5y)5.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.41%
GM growth 5Y36.9%
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.19
Debt/EBITDA N/A
Cap/Depr 520.54%
Cap/Sales 9.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z 1.78
F-Score4
WACC7.84%
ROIC/WACCN/A
Cap/Depr(3y)961.45%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.19%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-547.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y88.15%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-77.49%
Revenue growth 3Y-17.91%
Revenue growth 5Y-13.26%
Sales Q2Q%N/A
Revenue Next Year7.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-293.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.8%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y114.78%
FCF growth 3YN/A
FCF growth 5Y-13.29%
OCF growth 1Y16092.2%
OCF growth 3YN/A
OCF growth 5Y20.87%